Cargando…
A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial
Many potential therapeutic agents are discarded before they are tested in humans. These are not quack medications. They are drugs and other interventions that have been developed by responsible scientists in respectable companies or universities and are often backed up by publications in peer-review...
Autores principales: | Masters, Alexander, Nutt, Dominic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749301/ https://www.ncbi.nlm.nih.gov/pubmed/28588147 http://dx.doi.org/10.1136/medethics-2016-104050 |
Ejemplares similares
-
Randomised placebo-controlled trials of surgery: ethical analysis and guidelines
por: Savulescu, Julian, et al.
Publicado: (2016) -
Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them
por: Yarborough, Mark
Publicado: (2021) -
Ethical conflicts during the process of deciding about ICU admission: an empirically driven ethical analysis
por: Svantesson, Mia, et al.
Publicado: (2021) -
On the ethics of algorithmic decision-making in healthcare
por: Grote, Thomas, et al.
Publicado: (2020) -
Fertility preservation for transgender children and young people in paediatric healthcare: a systematic review of ethical considerations
por: Warton, Chanelle, et al.
Publicado: (2022)